Tag

Verarubin

All articles tagged with #verarubin

Nvidia Rolls Out Groq-Accelerated Inference Rack and Vera CPU Suite at GTC 2026
technology3 hours ago

Nvidia Rolls Out Groq-Accelerated Inference Rack and Vera CPU Suite at GTC 2026

Nvidia announced at GTC 2026 a Groq-based 3 LPX inference rack (256 LPUs, liquid-cooled, Spectrum-X interconnect) paired with the Vera Rubin NVL72 rack, plus a Vera CPU rack and BlueField-4 STX storage rack, all aimed at accelerating trillion-parameter AI models and agentic AI workloads. Rubin CPX products were put on hold to focus on LPX, with availability in H2 2026 and OEMs like Dell, HPE and Oracle Cloud.

Nvidia bets on $1 trillion Blackwell–Vera Rubin orders at GTC
technology20 hours ago

Nvidia bets on $1 trillion Blackwell–Vera Rubin orders at GTC

At Nvidia's GTC, CEO Jensen Huang forecast up to $1 trillion in purchase orders for the Blackwell and Vera Rubin AI systems by 2027, up from an earlier $500 billion projection, as demand from startups and large enterprises accelerates; the company unveiled the Groq 3 LPU and a Kyber rack for Vera Rubin Ultra, plus a Groq LPX rack that Nvidia says boosts tokens-per-watt by up to 35x, and introduced NemoClaw for OpenClaw, while highlighting Uber's Drive AV partnership and approvals from automakers like Nissan, BYD, Geely, Isuzu and Hyundai building Level 4 on Drive Hyperion; Nvidia also flagged strong revenue growth with year-over-year sales around 77% to about $78 billion this quarter, reinforcing its position as a leading AI hardware supplier.

NVIDIA and Lilly Launch AI-Driven Lab to Accelerate Drug Discovery
technology2 months ago

NVIDIA and Lilly Launch AI-Driven Lab to Accelerate Drug Discovery

NVIDIA and Eli Lilly unveiled a first-of-its-kind AI co-innovation lab in the San Francisco Bay Area, committing up to $1 billion over five years to fuse Lilly’s biology and medicine expertise with NVIDIA’s AI and accelerated computing, via the BioNeMo platform and Vera Rubin architecture. The initiative will create a continuous learning system that links Lilly’s wet labs with computational dry labs for 24/7 AI-assisted experimentation, develop large biomedical foundation and frontier models, and extend into manufacturing, clinical development, and supply chains using robotics, digital twins, and physical AI. The lab is set to begin in South San Francisco this year, aiming to accelerate drug discovery and scale medicine production through enhanced AI infrastructure and collaboration between the two companies’ experts and ecosystems.